Cardiff Oncology Inc

Cardiff Oncology Inc Stock

—P/E
€63.51MMarket capitalisation
-US$0.54Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targetingtumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.

Cardiff Oncology Inc is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Cardiff Oncology Inc stock.

Market capitalisation
€63.51M
P/E
—
P/B
2.22
P/S
104.17
P/CF
-1.41
Issued shares 78M Units

Return

Here you can see the performance of the Cardiff Oncology Inc stock.

PeriodPerfor­mance
1 Week+12.47 %
1 Month-6.65 %
3 Months+6.80 %
6 Months-46.60 %
1 Year-56.72 %
YTD-69.88 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Cardiff Oncology Inc share.

DateRatio
No data available.

Which ETF contains the Cardiff Oncology Inc stock?

The Cardiff Oncology Inc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Cardiff Oncology Inc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Cardiff Oncology Inc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.